Mark L. Bagarazzi
2016
In 2016, Mark L. Bagarazzi earned a total compensation of $1.4M as Chief Medical Officer at Inovio Pharmaceuticals, a 37% increase compared to previous year.
Compensation breakdown
| Bonus | $156,311 |
|---|---|
| Option Awards | $290,838 |
| Salary | $408,458 |
| Stock Awards | $526,500 |
| Other | $11,683 |
| Total | $1,393,790 |
Bagarazzi received $526.5K in stock awards, accounting for 38% of the total pay in 2016.
Bagarazzi also received $156.3K in bonus, $290.8K in option awards, $408.5K in salary and $11.7K in other compensation.
Rankings
In 2016, Mark L. Bagarazzi's compensation ranked 6,619th out of 14,075 executives tracked by ExecPay. In other words, Bagarazzi earned more than 53.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,619 out of 14,075 | 53rd |
Division Manufacturing | 2,457 out of 5,489 | 55th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 331 out of 827 | 60th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 178 out of 510 | 65th |
Industry Surgical and Medical Instruments and Apparatus | 96 out of 313 | 69th |
Source: SEC filing on March 29, 2017.
Bagarazzi's colleagues
We found three more compensation records of executives who worked with Mark L. Bagarazzi at Inovio Pharmaceuticals in 2016.